Biotech

All Articles

iTeos- GSK's TIGIT superstar reveals meaningful remodeling

.After revealing a stage 3 launch based upon beneficial midstage results, iTeos and also GSK are fin...

More collective FDA can easily speed up uncommon illness R&ampD: record

.The FDA should be actually even more open and joint to discharge a surge in approvals of unusual ai...

Zenas, MBX, Bicara head to Nasdaq in hot time for biotech IPOs

.It is actually an abnormally active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...

Atea's COVID antiviral neglects to stop hospital stays in stage 3

.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 test, but the biotec...

Neurocrine's quote to conserve schizophrenia possibility fails

.Neurocrine Biosciences' schizophrenia system pivot has actually fallen short. The biotech was incap...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has created an overdue access to the radioligand party, paying one hundred thousand european...

F 2G increases $100M for second try to acquire brand new antifungal to market

.After F2G's very first attempt to get a new course of antifungal to market was hindered by the FDA,...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 plans amid profitability stress

.Moderna has sworn to cut R&ampD investing through $1.1 billion by 2027. The selection to shrink the...

Sanofi's $80M bet on Fulcrum dystrophy drug finishes in period 3 fail

.Merely 4 months after Sanofi bet $80 thousand in upfront cash on Pivot Therapies' losmapimod, the c...

Oncternal share sinks 60% surrounded by discharges, test terminations

.Cancer company Oncternal Rehabs is actually folding all its clinical trials and also laying off sta...